Innovative Solutions, Expert Support, and Transparent Practices
EvidentIQ Group provides specialized eClinical software for organisations in the clinical research sector. Our solutions include Electronic Data Capture, eCOA, ePRO, eTMF, and clinical trial management systems. We complement our software by data science capabilities, patient recruitment services, and real-world evidence solutions. Together, these offerings support controlled, data-driven execution of clinical trials across their full operational scope.
The EvidentIQ Group is a leading provider of modern eClinical solutions designed specifically for experts in clinical research.
Our focus continues to remain on improving clinical trial execution by prioritizing four core performance parameters: time, quality, cost, and flexibility. These principles guide the design and operation of our platforms to support efficient, reliable, and scalable clinical research.
Accelerating Your Path to Successful Trials
Maximizing Value with 0 Compromises
Delivering Excellence at Every Step
Customisation and Scalability
1997
Fortress Medical System (FMS) was founded in Minnesota, USA.
FMS launched its solution Clindex
2002
XClinical was founded in Munich, Germany.
XClinical launched its solution Marvin EDC.
2006
Dacima Sofware was founded in Montréal, Canada.
Dacima Software launched its solutions Dacima EDC.
2019
Movember is creating the world’s largest prostate cancer patient registry network, harnessing real-world data from over 130,000 men to transform treatment and care. In a landmark partnership, Dacima Software will design a cutting-edge registry database, integrating global patient data for improved outcomes, faster clinical trials, and personalized care.
2020
Marvin, Carenity and Fortress Medical System merge to one company.
2021
The EvidentIQ Group was founded.
Marvin and Clindex are now officially brands of the EvidentIQ Group.
Carenity – the RWE experts launch their PatientLive® solution to provide access to an online community of 500,000 patients and caregivers
2022
Dacima EDC becomes the third brand in the EvidentIQ group.Dacima EDC becomes the third brand in the EvidentIQ group.
2023
Asthenis the expert for tumor documentation are joining EvidentIQ Group.
2024
2026
Marvin and Asthenis are now part of European based AB Cube.